16 April 2026 - Australian regenerative medicine company Orthocell Limited (ASX: OCC) announced on Thursday that it has secured approval for its Remplir nerve repair device to be used across the United States Department of Defence and Veterans Affair...
16 April 2026 - Adimab LLC, a provider of therapeutic antibody discovery and engineering technologies, said on Wednesday that it congratulates biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) for recently receiving approvals from the European C...
16 April 2026 - Research-based biopharmaceutical company Seragon Biosciences Inc announced on Wednesday the publication of comprehensive preclinical study results in the peer-reviewed journal Drug Design, Development and Therapy, demonstrating that i...